Document Detail


Percutaneous occlusion of left atrial appendage with the Amplatzer Cardiac PlugTM in atrial fibrillation.
MedLine Citation:
PMID:  22286325     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Atrial fibrillation is associated with embolic strokes that often result in death or disability. Effective in reducing these events, anticoagulation has several limitations and has been widely underutilized. Over 90% of thrombi identified in patients with atrial fibrillation without valvular disease originate in the left atrial appendage, whose occlusion is investigated as an alternative to anticoagulation.
OBJECTIVE: To determine the feasibility of percutaneous occlusion of the left atrial appendage in patients at high risk of embolic events and limitations to the use of anticoagulation.
METHODS: We report our initial experience with Amplatzer Cardiac Plug™ (St. Jude Medical Inc., Saint Paul, Estados Unidos) in patients with nonvalvular atrial fibrillation. We selected patients at high risk of thromboembolism, major bleeding, contraindications to the use or major instability in response to the anticoagulant. The procedures were performed percutaneously under general anesthesia and transesophageal echocardiography. The primary outcome was the presence of periprocedural complications and follow-up program included clinical and echocardiographic review within 30 days and by telephone contact after nine months.
RESULTS: In five selected patients it was possible to occlude the left atrial appendage without periprocedural complications. There were no clinical events in follow-up.
CONCLUSION: Controlled clinical trials are needed before percutaneous closure of the left atrial appendage should be considered an alternative to anticoagulation in nonvalvular atrial fibrillation. But the device has shown to be promissory in patients at high risk of embolism and restrictions on the use of anticoagulants.
Authors:
Márcio José Montenegro; Edgard Freitas Quintella; Aníbal Damonte; Hugo de Castro Sabino; Ricardo Zajdenverg; Gustavo Pinaud Laufer; Bernardo Amorim; André Pereira Duque Estrada; Cristian Paul Yugcha Armas; Aline Sterque
Related Documents :
22548915 - The importance of intima-media thickness (imt) measurements in monitoring of atheroscle...
8677865 - Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mell...
21959715 - Late angiograms ten years after transmyocardial laser revascularization.
21902655 - Optimal medical therapy for coronary artery disease in 2011 - perspectives from the sti...
19272135 - A combination of left ventricular noncompaction and double orifice mitral valve.
17804775 - Hepatic infarction after radiofrequency ablation of hepatocellular carcinoma with an in...
Publication Detail:
Type:  Journal Article     Date:  2012-01-31
Journal Detail:
Title:  Arquivos brasileiros de cardiologia     Volume:  98     ISSN:  1678-4170     ISO Abbreviation:  Arq. Bras. Cardiol.     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-03-01     Completed Date:  2012-10-18     Revised Date:  2014-07-30    
Medline Journal Info:
Nlm Unique ID:  0421031     Medline TA:  Arq Bras Cardiol     Country:  Brazil    
Other Details:
Languages:  eng; por     Pagination:  143-50     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anticoagulants / contraindications*
Atrial Appendage*
Atrial Fibrillation / therapy*,  ultrasonography
Feasibility Studies
Female
Follow-Up Studies
Humans
Intracranial Embolism / prevention & control*
Male
Middle Aged
Retrospective Studies
Septal Occluder Device* / adverse effects
Stroke / prevention & control*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anticoagulants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Multislice coronary angiotomography in the assessment of coronary artery anomalous origin.
Next Document:  Evaluation of accuracy of rastreometer: a new equipment for hypertension tracking.